Gut microbiota- and probiotic-derived bioactive metabolites: mechanisms, evidence, and therapeutic potential in metabolic disorders.

Akpor OB, Ajinde AO

Open source

DOI
10.3389/fcimb.2026.1953273
Published
2026
Container
Frontiers in cellular and infection microbiology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fcimb.2026.1953273,
  title = {Gut microbiota- and probiotic-derived bioactive metabolites: mechanisms, evidence, and therapeutic potential in metabolic disorders.},
  author = {Akpor OB and Ajinde AO},
  year = {2026},
  journal = {Frontiers in cellular and infection microbiology},
  doi = {10.3389/fcimb.2026.1953273},
  url = {https://doi.org/10.3389/fcimb.2026.1953273}
}

RIS

TY  - JOUR
TI  - Gut microbiota- and probiotic-derived bioactive metabolites: mechanisms, evidence, and therapeutic potential in metabolic disorders.
AU  - Akpor OB
AU  - Ajinde AO
PY  - 2026
JO  - Frontiers in cellular and infection microbiology
DO  - 10.3389/fcimb.2026.1953273
UR  - https://doi.org/10.3389/fcimb.2026.1953273
ER  - 

APA

OB, A., & AO, A. (2026). Gut microbiota- and probiotic-derived bioactive metabolites: mechanisms, evidence, and therapeutic potential in metabolic disorders.. Frontiers in cellular and infection microbiology. https://doi.org/10.3389/fcimb.2026.1953273

Source records